|View printer-friendly version|
|Invuity Inc. Showcased PhotonBlade at Premier Inc.’s Annual Breakthroughs Conference|
PhotonBlade was debuted during the conference’s annual Innovation Celebration. The event recognizes advances in healthcare while highlighting industry suppliers committed to innovation and improving patient outcomes.
“Invuity shares Premier’s commitment to providing valuable products to our alliance members that are safe, high-quality and cost-effective,” said
Clinicians and other health system members of Premier selected PhotonBlade to be showcased at the Innovation Celebration due to its uniqueness, ability to have an impact on unmet clinical needs and potential to improve patient care.
For surgeons who perform minimal access surgery, PhotonBlade provides direct, thermally cool illumination at the precise point of surgical treatment. Further, PhotonBlade’s novel energy platform consists of a proprietary coated blade for precise cutting and coagulation of tissue, with minimal collateral effect. This sophisticated illumination technology further allows for unique use in a fluid filled environment and does not require a proprietary generator, thereby leveraging widely available operating room equipment and avoiding an institutional capital investment. PhotonBlade provides exceptional visualization within the surgical cavity, for precision and safety.
“We are honored to have received this recognition from Premier,” stated President and CEO of Invuity Philip Sawyer. “It demonstrates the consistent goals of both
Any supplier, regardless of whether the company is contracted with Premier, can be considered for participation in the Innovation Celebration. Premier contracts with more than 1,200 suppliers.
For more detailed information, including a video of PhotonBlade visit: http://breakthroughs.premierinc.com/innovation-celebration-2017/
About Invuity® Inc.
This announcement contains forward-looking statements that involve risks and uncertainties, including statements regarding expectations for PhotonBlade, future product development and our commercial strategies. Actual results could differ materially from those projected in the forward-looking statements as a result of certain risk factors, including, but not limited to: fluctuations in demand or failure to gain market acceptance for the Company's devices; the Company's ability to demonstrate to and gain approval from hospitals to use the Company's devices; the highly competitive business environment for surgical medical devices; the Company's ability to sell its devices at prices that support its current business strategies; difficulty forecasting future financial performance; protection of the Company's intellectual property; and compliance with necessary regulatory clearances or approvals. The Company undertakes no obligation to update the forward-looking information in this release. More information about potential factors that could affect the Company's business and financial results is included in its filings with the
CONTACT: Company Contact: